Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
597 | 13382 | 31.6 | 77% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
183 | 51952 | HEPATOCELLULAR CARCINOMA//CONTRAST MEDIA//LIVER RESECTION |
Classes in level below (level 1) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HEPATOCELLULAR CARCINOMA | Author keyword | 1410 | 27% | 34% | 4525 |
2 | HEPATOBLASTOMA | Author keyword | 518 | 68% | 3% | 456 |
3 | GLYPICAN 3 | Author keyword | 261 | 82% | 1% | 150 |
4 | TRANSARTERIAL CHEMOEMBOLIZATION | Author keyword | 205 | 61% | 2% | 219 |
5 | MILAN CRITERIA | Author keyword | 173 | 82% | 1% | 102 |
6 | DES GAMMA CARBOXY PROTHROMBIN | Author keyword | 137 | 86% | 1% | 71 |
7 | CHEMOEMBOLIZATION | Author keyword | 123 | 41% | 2% | 236 |
8 | TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION | Author keyword | 116 | 50% | 1% | 166 |
9 | MIRIPLATIN | Author keyword | 99 | 97% | 0% | 29 |
10 | ALPHA FETOPROTEIN | Author keyword | 92 | 22% | 3% | 368 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HEPATOCELLULAR CARCINOMA | 1410 | 27% | 34% | 4525 | Search HEPATOCELLULAR+CARCINOMA | Search HEPATOCELLULAR+CARCINOMA |
2 | HEPATOBLASTOMA | 518 | 68% | 3% | 456 | Search HEPATOBLASTOMA | Search HEPATOBLASTOMA |
3 | GLYPICAN 3 | 261 | 82% | 1% | 150 | Search GLYPICAN+3 | Search GLYPICAN+3 |
4 | TRANSARTERIAL CHEMOEMBOLIZATION | 205 | 61% | 2% | 219 | Search TRANSARTERIAL+CHEMOEMBOLIZATION | Search TRANSARTERIAL+CHEMOEMBOLIZATION |
5 | MILAN CRITERIA | 173 | 82% | 1% | 102 | Search MILAN+CRITERIA | Search MILAN+CRITERIA |
6 | DES GAMMA CARBOXY PROTHROMBIN | 137 | 86% | 1% | 71 | Search DES+GAMMA+CARBOXY+PROTHROMBIN | Search DES+GAMMA+CARBOXY+PROTHROMBIN |
7 | CHEMOEMBOLIZATION | 123 | 41% | 2% | 236 | Search CHEMOEMBOLIZATION | Search CHEMOEMBOLIZATION |
8 | TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION | 116 | 50% | 1% | 166 | Search TRANSCATHETER+ARTERIAL+CHEMOEMBOLIZATION | Search TRANSCATHETER+ARTERIAL+CHEMOEMBOLIZATION |
9 | MIRIPLATIN | 99 | 97% | 0% | 29 | Search MIRIPLATIN | Search MIRIPLATIN |
10 | ALPHA FETOPROTEIN | 92 | 22% | 3% | 368 | Search ALPHA+FETOPROTEIN | Search ALPHA+FETOPROTEIN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTRAHEPATIC RECURRENCE | 598 | 69% | 4% | 511 |
2 | TRANSARTERIAL CHEMOEMBOLIZATION | 415 | 56% | 4% | 503 |
3 | LIPIODOL CHEMOEMBOLIZATION | 338 | 78% | 2% | 221 |
4 | MILAN CRITERIA | 297 | 77% | 2% | 204 |
5 | TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION | 290 | 48% | 3% | 447 |
6 | CHILDHOOD HEPATOBLASTOMA | 255 | 89% | 1% | 115 |
7 | GAMMA CARBOXY PROTHROMBIN | 251 | 69% | 2% | 215 |
8 | OILY CHEMOEMBOLIZATION | 239 | 83% | 1% | 137 |
9 | CLIP SCORE | 237 | 81% | 1% | 142 |
10 | PERCUTANEOUS ETHANOL INJECTION | 222 | 39% | 3% | 454 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
CURRENT CONCEPTS Hepatocellular Carcinoma | 2011 | 729 | 50 | 54% |
Hepatocellular carcinoma | 2003 | 2247 | 114 | 69% |
Management of hepatoceullular carcinoma | 2005 | 2778 | 295 | 58% |
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference | 2001 | 2277 | 114 | 66% |
Prognosis of hepatocellular carcinoma: The BCLC staging classification | 1999 | 1069 | 43 | 100% |
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival | 2003 | 1230 | 80 | 69% |
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report | 2012 | 151 | 82 | 93% |
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma | 2010 | 557 | 12 | 50% |
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization | 2011 | 129 | 90 | 92% |
Hepatocellular Carcinoma: Reasons for Phase III Failure and Novel Perspectives on Trial Design | 2014 | 25 | 42 | 67% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MT SINAI LIVER CANC PROGRAM | 43 | 62% | 0.3% | 44 |
2 | LIVER CANC | 34 | 18% | 1.3% | 175 |
3 | UNITA SEMEIOT MED | 31 | 92% | 0.1% | 12 |
4 | BCLC GRP | 30 | 68% | 0.2% | 27 |
5 | BARCELONA CLIN LIVER CANC BCLC GRP | 15 | 82% | 0.1% | 9 |
6 | BARCELONA CLIN LIVER CANC GRP | 14 | 55% | 0.1% | 18 |
7 | YONSEI LIVER CANC SPECIAL CLIN | 12 | 53% | 0.1% | 16 |
8 | BARCELONA CLIN LIVER CANC BCLC GRPLIVER UNIT | 12 | 86% | 0.0% | 6 |
9 | LIVER TUMOR PROGRAM | 11 | 65% | 0.1% | 11 |
10 | EASTERN HEPATOBILIARY SURG HOSP | 11 | 12% | 0.7% | 91 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000036573 | RADIO FREQUENCY ABLATION//LIVER RESECTION//LIVER METASTASES |
2 | 0.0000027720 | FOCAL NODULAR HYPERPLASIA//GD EOB DTPA//GADOXETIC ACID |
3 | 0.0000012226 | PERSISTENT SCIATIC ARTERY//MEDIAN ARCUATE LIGAMENT SYNDROME//CELIAC TRUNK |
4 | 0.0000009045 | STEREOTACTIC BODY RADIOTHERAPY//4D CT//STEREOTACTIC BODY RADIATION THERAPY |
5 | 0.0000008498 | GLASGOW PROGNOSTIC SCORE//NEUTROPHIL TO LYMPHOCYTE RATIO//NEUTROPHIL LYMPHOCYTE RATIO |
6 | 0.0000007768 | POLYCYSTIC LIVER DISEASE//BILIARY CYSTADENOCARCINOMA//BILIARY CYSTADENOMA |
7 | 0.0000006690 | HEPATITIS B VIRUS//CHRONIC HEPATITIS B//HEPATITIS B |
8 | 0.0000005947 | LIVER TRANSPLANTATION//LIVING DONOR LIVER TRANSPLANTATION//HEPATIC ARTERY THROMBOSIS |
9 | 0.0000005796 | MODY//MATURITY ONSET DIABETES OF THE YOUNG//NEONATAL DIABETES |
10 | 0.0000005681 | DCE MRI//CT PERFUSION//INTRAVOXEL INCOHERENT MOTION |